Abstract: Like subclavian artery disease, innominate artery disease can result in reversal of flow in the ipsilateral vertebral artery. Unlike subclavian artery disease, innominate artery disease can also affect cerebral perfusion in the ipsilateral carotid territory, is less well characterized in the literature, and is more challenging to revascularize. Herein, we present two cases of 'innominate steal' and a summary of relevant literature focusing on innominate artery disease.
Introduction
Subclavian steal phenomenon is the reversal of vertebral artery flow due to an ipsilateral proximal subclavian or innominate artery stenosis. Reversal of flow in the vertebral artery ipsilateral to the subclavian or innominate stenosis is caused by a pressure drop distal to the stenosis that causes blood flow to course down its pressure gradient from the basilar artery to the ipsilateral arm.
Subclavian steal syndrome is the presence of subclavian steal phenomenon associated with symptoms of vertebrobasilar insufficiency, such as vertigo, dizziness, diplopia, ataxia, and nausea [1] .
Subclavian steal phenomenon is often asymptomatic, as an intact circle of Willis enables adequate perfusion of the posterior cerebrum despite flow reversal in a vertebral artery. Similarly, though a marker for atherosclerotic disease, the natural history of subclavian steal phenomenon/syndrome is thought to be relatively benign with a low incidence of ipsilateral posterior circulation cerebrovascular events [2] .
Subclavian steal phenomenon/syndrome is more commonly encountered on the left as left subclavian artery atherosclerosis is 3-5 times more common than right-sided disease for unknown reasons [3] . When vertebral flow reversal occurs on the right, it can be a result of either subclavian or innominate artery stenosis or occlusion. Innominate artery disease can cause not only vertebral flow reversal but also flow reversal in the ipsilateral carotid system. Flow reversal in both the right vertebral and carotid systems has been termed 'double subclavian steal', 'innominate steal', and 'cerebral steal' [4] . We will refer to it as 'innominate steal'.
Compared to subclavian steal, innominate steal is less well characterized. It was first described clinically in 1966 [5] . It is less common than subclavian steal phenomenon, but the proportion of patients who are symptomatic is likely higher with innominate versus subclavian steal. Both surgical and endovascular treatment of innominate obstructive disease are more complex than for subclavian disease [6] [7] [8] [9] [10] .
Herein, we present two cases of innominate steal syndrome, review the clinical manifestations and imaging findings of this disorder, describe treatment options, and summarize the sparse relevant literature.
Case 1
A 55 year-old male presented with episodes of dizziness and nausea that had worsened over the past 6 months. The dizzy spells were associated with visual "black spots" and were worse while working with his right hand. He had a history of hypertension, hyperlipidemia, tobacco abuse, and peripheral arterial disease and had undergone innominate artery stenting for symptoms of vertebrobasilar insufficiency three years prior. His medications included aspirin, amlodipine, and atorvastatin. He was a former smoker. On physical examination, the systolic blood pressure in the left arm was 125 mmHg, and the systolic blood pressure in the right arm was 80 mmHg. The pertinent pulse exam is described in Table 1 . At a 30-day follow-up visit, he had resolution of his neurological symptoms.
Case 2
A 43 year-old male was hospitalized with heart failure after a recent 3-vessel coronary artery bypass graft surgery, ascending aorta replacement, and failed aortic valve replacement due to a small annulus. He was found to have severe left ventricular outflow obstruction, aortic valve stenosis and regurgitation, and findings consistent with constrictive pericarditis. He underwent redo sternotomy with aortic valve replacement with annulus enlargement and epicardial stripping. He was also known to have an innominate artery occlusion; however, this lesion was not addressed during the above surgeries as it was felt to be asymptomatic.
Post-operatively, he was noted to have positional episodes of left arm and leg weakness with confusion upon standing. These episodes were reliably reproduced with position change and were not correlated with orthostatic hypotension. His pulse exam is described in Table 1 The patient tolerated the procedure well without apparent complications. Post-procedure he had no further episodes of what was felt to be innominate steal syndrome. He was discharged on hospital day 25.
Discussion
The cause of innominate artery disease is most frequently atherosclerosis. Other potential etiologies include Takayasu arteritis, giant cell arteritis, radiation, and fibromuscular dysplasia [11] .
Clinical manifestations of innominate steal can include symptoms referable to the posterior circulation (dizziness, vertigo, ataxia, diplopia, bilateral limb weakness), symptoms referable to ICA territory ischemia (e.g., global cerebral hypoperfusion, amaurosis, aphasia, left hemiparesis), or exertional right upper extremity discomfort [6, 11] . Some suggest that symptoms of cerebral hypoperfusion in innominate stenosis typically occur in the setting of additional occlusive disease in the cerebral circulation [12] . However, there are small case series of patients with hemispheric symptoms in the setting of innominate stenosis that have demonstrated objective evidence of reduced regional cerebral blood flow (rCBG) by SPECT imaging in the absence of other intra or extra cranial disease [13] . Isolated innominate disease was present in both cases presented above.
The prevalence of clinically significant innominate stenosis is likely low. In 4748 patients with suspected cerebrovascular disease referred for angiography, the prevalence on innominate stenosis was only 2.5% [1] . Of 20,000 patients undergoing duplex ultrasonography in a single institution in Europe, only 3 were found to have hemispheric steal [2] . The majority of patients with innominate artery stenosis have atherosclerotic disease and should receive aggressive secondary prevention measures. Clinical practice guidelines give a Class IIA recommendation (the weight of evidence is in favor of usefulness) for innominate revascularization for symptomatic disease or when an ipsilateral internal mammary artery is needed for coronary bypass based on expert opinion [11] .
Revascularization of innominate disease can be performed percutaneously or surgically. In contrast to subclavian artery obstructive disease, which can be treated extra-anatomically, surgical innominate revascularization often requires a transthoracic approach and carries relatively high morbidity and mortality. In 3 studies of 327 patients undergoing transthoracic revascularization for disease of the great vessels in the 1990's, the combined perioperative stroke and death rate ranged from 8-16% [16] [17] [18] . Thus, endovascular or hybrid techniques are favored currently.
There are no randomized trial data and only sparse observational evidence regarding percutaneous innominate revascularization (Table 2 ). More reports exist that pool innominate and subclavian outcomes. Across several small series summarized in Table 2 that specifically report innominate interventions, the success rate of angioplasty/stenting is typically 90-100%; the periprocedural neurologic event rate is low but not insignificant (TIA 4.3%, stroke 1%), and the patency is fairly good [19] [20] [21] [22] [23] . Several technical aspects make innominate intervention challenging. In particular, the use of distal embolic protection is desirable at least in theory. However, it can be difficult to maintain such a device, designed for placement in the distal cervical internal carotid artery, in the field of view when treating the innominate. Also, appropriately sized stents are often compatible with a 0.035-inch guidewire, whereas distal embolic protection devices are 0.014-inch systems. Another challenge of innominate intervention can be achieving adequate guiding catheter or sheath support in the aortic arch to cross the lesion and deliver equipment. We attempted to obviate some of these issues in the first case by advancing a 0.018-inch wire to the axillary artery to provide extra guiding catheter support while deploying a stent compatible with the wire of the distal embolic protection system. Such a two-wire approach has been reported in the past [24] .
A final technical challenge of note is preserving important side branches. In the second case, the occlusion was 'flanked' by the right and left common carotid arteries, respectively. The use of 'kissing' stents in this case protected the left common carotid artery.
Longitudinal follow-up of patients following innominate revascularization is important given the not insignificant restenosis rates and the potential for neurologic symptoms. Physical examination, including bilateral noninvasive arm blood pressures, is critical for detecting restenosis. Likewise, extracranial vertebral and carotid duplex ultrasound can be used to ensure there is antegrade flow in the right vertebral and carotid arteries. There is no evidence to guide the use of antiplatelet agents in this setting. We favor dual antiplatelet therapy for 3 months and indefinite mono-antiplatelet therapy, thereafter.
Conclusion
Similar to subclavian steal syndrome, innominate steal can involve vertebrobasilar insufficiency but also can be associated with cerebral ischemia in the right internal carotid territory. Surgical revascularization of innominate disease carries higher morbidity and mortality than that for subclavian artery stenosis. Hence, percutaneous revascularization is often favored. We have presented two cases, which illustrate typical clinical presentations of innominate steal and also highlight several technical challenges of endovascular treatment of this disorder.
